Manufacturer high purity CAS 1197-18-8 Tranexamic Acid

Tranexamic acid, also called tranexamic acid, is a synthetic derivative of lysine with a similar structure to tyrosine. Confirmed by clinical trials, it is suitable for all types of skin and can remove pigmentation, whiten, and lighten spots, such as: pigmentation after sun exposure, dark spots (chloasma, freckles, senile lentils, etc.), sensitive skin, Acne and inflammation, post-operative care after laser, pulsed light treatment, etc. Therefore, tranexamic acid can be recommended for use in cosmetics such as creams, lotions, essences, lotions, and facial masks.

Tranexamic acid is a synthetic amino acid antifibrinolytic drug that can competitively inhibit the binding of lysine in fibrin to plasmin, thereby inhibiting the lysis of fibrin clots and producing hemostasis. It is mainly used clinically. For various types of bleeding caused by hyperfibrinolysis.

Tranexamic acid Applications

1. Tranexamic acid is an anti-fibrinolytic drug, it can treat various acute and chronic bleeding and achieve hemostasis.

2.Tranexamic acid can reduce melanin production: It can directly compete with tyrosine in cells, inhibit the catalytic effect of tyrosine metabolism, and reduce melanin production.

3. Inhibit angiogenesis: It can directly compete with tyrosine in cells, inhibit the catalytic effect of tyrosine metabolism, and inhibit skin angiogenesis. This can reduce the number of blood vessels in and around chloasma lesions, reduce the occurrence of inflammatory reactions, and thereby reduce the continuous formation of chloasma.

4.Tranexamic acid can reduce the expression of pro-inflammatory cytokines and chemokines to exert anti-inflammatory effects, which can effectively prevent the occurrence of allergic reactions and reduce the formation of acne.

5. Tranexamic acid has Anti-aging and anti-photoaging properties. It enhances hyaluronic acid synthesis by increasing the number of epidermal cells, reduces the degradation of extracellular matrix in the dermis by blocking plasmin, and can reduce the levels of some oxidative substances in the blood to improve the natural aging of the skin. Improves UVB-induced photoaging by increasing mitochondrial biogenesis, regulating hormone secretion by increasing the expression of estrogen receptors on the surface of mast cells, and improving UVA-induced photoaging.

Tranexamic acid Specification

Hebei WeiBang Biotechnology Co., Ltd

Add: Yuhua West Road, Qiaoxi District,Shijiazhuang City, Hebei Province

Product Name	Tranexamic acid	CAS No	1197-18-8
Production Date	2023/12/01	Report Date	2023/12/01
Quantity	10,000KG	Test Date	2023/12/01
BatchNo	WB20231201	Shelf life	2 years
Testing Items	Specification
Appearance	White crystal powder
Identification	IR
Loss on drying	≤0.50%
pH	7.0-8.0
Assay	≥99.0
Sulphated ash	≤0.10%
Related substance	Impurity A: ≤0.10%
	Impurity B: ≤0.20%
	Any other impurity: ≤0.10%
	All other impurity: ≤0.20%
Chlorides	≤140ppm
Total plate count	≤1000cfu/g
Yeast & mould	≤100cfu/g
Pb	≤10mg/kg
As	≤2mg/kg
Hg	≤1mg/kg
Cd	≤5mg/kg
Conclusion	Qualified